Pieper Steven
See Remarks
2 filings on record here, covering XERS, PUBM. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-12
| Sell | XERS | Xeris Biopharma Holdings, Inc. | $42,500 |
CORPORATEFiled 2026-07-06
| Exercise | PUBM | PubMatic, Inc. | |
| Sell | PUBM | PubMatic, Inc. | $321,395 |
| Sell | PUBM | PubMatic, Inc. | $168,336 |
| Exercise | PUBM | PubMatic, Inc. | |
| Exercise | PUBM | PubMatic, Inc. | |
| Exercise | PUBM | PubMatic, Inc. | |
| Exercise | PUBM | PubMatic, Inc. | |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.